Latest filing published 13 Mar 2025 for Dyne Therapeutics, Inc., €23k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Oxana Beskrovnaya: trading record in brief
All filings by Oxana Beskrovnaya on record concern Dyne Therapeutics, Inc., in the capacity of senior executive. The record holds 42 filings, for trades running from 17 September 2020 to 11 March 2025.
Every open-market trade on record is a sale: 30 sales worth €3.2M. The rest of the record consists of 6 share grants and 3 option exercises. 2025 to date brings no purchases and 3 sales.
Most recently, on 13 March 2025, the filings show an open-market sale worth €23k in Dyne Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Oxana Beskrovnaya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,153 shares@ US$11.382.6% of flowCommon StockSEC:0000950170-25-038726:0
- 1,094 shares@ US$11.831.4% of flowCommon StockSEC:0000950170-25-035472:0
- 2,598 shares@ US$13.953.9% of flowCommon StockSEC:0000950170-25-026837:0
- 2,334 shares@ US$28.127.1% of flowCommon StockSEC:0000950170-24-135571:0
- 39,100 shares0Common StockSEC:0000950170-24-134070:0
- 2,856 shares@ US$28.208.7% of flowCommon StockSEC:0000950170-24-127989:0
- 2,339 shares@ US$34.558.3% of flowCommon StockSEC:0000950170-24-108151:0
- 2,161 shares@ US$31.897.1% of flowCommon StockSEC:0000950170-24-105517:0
- 2,340 shares@ US$45.0110.8% of flowCommon StockSEC:0000950170-24-099122:0
- 296 shares@ US$46.001.4% of flowCommon StockSEC:0000950170-24-099122:1
- 2,136 shares@ US$31.347.1% of flowCommon StockSEC:0000950170-24-072170:0
- 30,426 shares@ US$1.033.3% of flowCommon StockSEC:0000950170-24-063737:0
- 2,222 shares@ US$28.206.6% of flowCommon StockSEC:0000950170-24-062080:0
- 2,081 shares@ US$25.705.6% of flowCommon StockSEC:0000950170-24-030443:0
- 2,373 shares@ US$25.856.4% of flowCommon StockSEC:0000950170-24-029615:0
- 45,326 shares@ US$1.034.9% of flowCommon StockSEC:0000950170-24-002279:0
- 1,467 shares@ US$10.721.7% of flowCommon StockSEC:0001209191-23-058326:0
- 93,718 shares0Common StockSEC:0001209191-23-055521:0
- 1,436 shares@ US$9.4110.9% of flowCommon StockSEC:0001209191-23-050168:0
- 1,484 shares@ US$10.411.6% of flowCommon StockSEC:0001209191-23-049356:0
- 1,475 shares@ US$12.431.9% of flowCommon StockSEC:0001209191-23-037163:0
- 1,416 shares@ US$13.332.0% of flowCommon StockSEC:0001209191-23-018977:0
- 40,000 shares0Common StockSEC:0001209191-22-060964:0
- 1,413 shares@ US$13.702.2% of flowCommon StockSEC:0001209191-22-050881:0
- 712 shares@ US$14.051.1% of flowCommon StockSEC:0001209191-22-050117:0
25 of 29 declarations
